IP Library Granted Patent US 11,530,286
Granted Patent B2
US 11,530,286 · App. 16/305,576 · Granted Dec 20, 2022

Sulfobetaine-based protein aggregation inhibitor for use in preventing aggregation of a protein

Inventors: Kazuaki Matsumura (Nomi, JP); Rajan Robin (Nomi, JP); Yoko Taniyama (Hakusan, JP); Yoshiyuki Saruwatari (Osaka, JP)
Assignees: OSAKA ORGANIC CHEMICAL INDUSTRY LTD.; JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
C08F291/14C12N9/2462C12N9/96C12Y302/01017C08F2810/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,530,286
App. No.
16/305,576
Granted
Dec 20, 2022
Kind
B2
Abstract

The present invention provides a protein aggregation inhibitor for use in preventing aggregation of a protein, containing a crosslinked polymer obtained by polymerizing polymerizable polymer components containing a sulfobetaine polymer obtained by polymerizing monomer components containing a sulfobetaine monomer, the sulfobetaine monomer, and a crosslinkable monomer.

Claims (15)

1. A protein aggregation inhibitor for use in preventing aggregation of a protein, the inhibitor comprising a crosslinked polymer obtained by polymerizing polymerizable polymer components comprising

a sulfobetaine polymer obtained by polymerizing monomer components comprising a sulfobetaine monomer,

the sulfobetaine monomer, and

a crosslinkable monomer,

wherein the sulfobetaine monomer is represented by the formula (I):

wherein R 1 is a hydrogen atom or a methyl group, R 2 is an alkylene group having 1-4 carbon atoms, R 3 is an alkyl group having 1-4 carbon atoms, R 4 is an alkylene group having 1-4 carbon atoms, and X is an —NH— group or an —O— group.

2. The protein aggregation inhibitor according to claim 1 , wherein the monomer components further comprise a thiocarbonylthio group-containing compound having at least one carboxyl group.

3. The protein aggregation inhibitor according to claim 1 , wherein the polymerizable polymer components further comprise a hydrophobic monomer.

4. A method of producing a protein aggregation inhibitor for use in preventing aggregation of a protein and comprising a crosslinked polymer, the method comprising

polymerizing monomer components comprising a sulfobetaine monomer, and

polymerizing polymerizable polymer components comprising the resulting sulfobetaine polymer, the sulfobetaine monomer, and a crosslinkable monomer,

wherein the sulfobetaine monomer is represented by the formula (I):

wherein R 1 is a hydrogen atom or a methyl group, R 2 is an alkylene group having 1-4 carbon atoms, R 3 is an alkyl group having 1-4 carbon atoms, R 4 is an alkylene group having 1-4 carbon atoms, and X is an —NH— group or an —O— group.

5. The method according to claim 4 , wherein the monomer components are polymerized in the presence of a thiocarbonylthio group-containing compound having at least one carboxyl group.

6. The method according to claim 4 , wherein the polymerizable polymer components further comprise a hydrophobic monomer.

Assignments (2)
CHANGE OF ADDRESS Recorded Apr 15, 2022
From: OSAKA ORGANIC CHEMICAL INDUSTRY LTD.
To: OSAKA ORGANIC CHEMICAL INDUSTRY LTD.
Reel/Frame 059721/0809 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2018
From: MATSUMURA, KAZUAKI; ROBIN, RAJAN; TANIYAMA, YOKO; SARUWATARI, YOSHIYUKI
To: OSAKA ORGANIC CHEMICAL INDUSTRY LTD.; JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
Reel/Frame 047829/0969 →